Chacruna Institute for Psychedelic Plant Medicines is a registered California 501(c)(3) non-profit organization (EIN 84-3076078). We are a community-oriented organization run by a small staff of experts and enthusiastic volunteers who work to bring education and cultural understanding about psychedelic plant medicines to a wider audience. We promote a bridge between the ceremonial use of sacred plants and psychedelic science and envisage a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal, and health care systems.
Help us to achieve our mission! From our beginnings in 2017, we have stood apart from other psychedelic education and advocacy organizations by pioneering initiatives that support and provide a platform for diverse voices, including women, queer people, people of color, Indigenous people, and the Global South. In efforts to address the lack of diverse representation in the expanding psychedelic landscape, we centered our mission around the empowerment of marginalized voices to foster cultural and political reflections on topics like race, gender, and sexuality in psychedelic science. We believe now more than ever, given the current social and political climate, our work is critical to the future of psychedelic healing for humanity.
Please become a member so that you are able to help Chacruna, yourself, and the world. Support of any amount helps this cause and allows us to provide psychedelic education to anyone who wants to access it.
In clinical literature, psilocybin, DMT, and MDMA receive a great deal of attention, but, as Ana Camacho shows, the same is not true for the peyote cactus and mescaline. This article looks back on the history of the psychedelic substance in Western science to understand why it is not as popular today as it was during the mid-twentieth century.
Ayahuasca ceremonies have been recognized as both religious and therapeutic experiences by their practitioners for millennia. Today, research with this extraordinary visionary brew from...
Board Certified Psychiatric Pharmacists Dr.’s Ben Malcolm and Kelan Thomas recently published a review article discussing the risks of serotonin syndrome with various serotonergic psychedelics, either alone or in combination with serotonergic antidepressants. In this article, the authors offer a short summary of their main findings.
Laughter is the reaction I often face when I tell people that my research demonstrates that MDMA enhances empathy and that ayahuasca improves creativity....
Analysis of ayahuasca DNA by geneticists confirms lineages known to traditional users that might be three different species: tucunacá, caupuri, and pajezinho. This study represents a corroboration of traditional Indigenous knowledge with Western science.
Kelan Thomas writes about a new psilocybin group therapy clinical trial for demoralized AIDS survivors that was recently published by Chacruna board member Dr. Brian Anderson.